CAR T Cell Therapy in Delhi
Facing leukaemia or lymphoma can feel stressful, especially when standard treatments no longer bring the hope you once held on to. In such moments, CAR T-Cell Therapy in Delhi is transforming cancer care, offering a new ray of hope for patients with relapsed or resistant blood cancers by using the power of their own immune system to fight the disease.
Delhi has established itself as a leading destination for advanced CAR T-cell therapy in India, with access to specialised haematology-oncology experts and modern treatment facilities. If previous treatments have failed, CAR T-cell therapy may be a life-saving next step.
Reach Out for Expert Care
What is CAR T-Cell Therapy and How Does It Work?
CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) is an advanced treatment where a patient’s T-cells (a type of white blood cell) are modified in a laboratory to recognise and attack cancer cells.
How it works:
- T-cells are collected from the patient’s blood
- They are genetically modified to express CAR proteins
- These genetically modified cells are multiplied in the lab
- Then the cells are reinfused into the patient to target cancer cells
Unlike chemotherapy, CAR T therapy for leukemia and lymphoma is highly targeted, which reduces the chances of damage to healthy tissues.
What Types of Cancers Can Be Treated with CAR T Therapy?
In the best hospitals in Delhi offering CAR T-cell therapy, this treatment is used for treating:
- Acute lymphoblastic leukaemia (ALL)
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Mantle cell lymphoma
- Multiple myeloma
- B-cell non-Hodgkin lymphoma
Current research on solid tumours is making advanced immunotherapy for cancer in Delhi an evolving field.
When is CAR T-Cell Therapy Recommended?
CAR T-Cell Therapy in Delhi is usually a preferred option for patients with advanced or treatment-resistant blood cancers, especially when standard therapies have not delivered desired results. Doctors may recommend CAR T therapy in the following situations:
- Relapsed cancer: Cancer has returned after initial treatment
- Refractory cancer: Cancer is not responding to chemotherapy or targeted therapy
- Post-transplant relapse: Cancer returns after bone marrow transplant
- High-risk or aggressive disease types
- Limited response to multiple prior treatment lines
For many patients, CAR T therapy for leukemia and lymphoma becomes a critical choice when other treatments have failed.
Step-by-Step Process of CAR T-Cell Therapy
The CAR T therapy procedure steps typically include:
1. Leukapheresis (Cell Collection)
- T-cells are extracted from the blood
- Duration:3-4 hours
2. Genetic Engineering
- Cells are modified in a lab
- Duration: 2-4 weeks
3. Lymphodepletion Chemotherapy
- Prepares the body for CAR T-cell infusion
4. CAR T-Cell Infusion
- Modified cells infused via IV
- Duration: 30-90 minutes
5. Monitoring
- Close observation
- Duration 7–14 days
6. Response Evaluation
- Follow-up scans and bone marrow tests
CAR T-cell therapy is a highly advanced form of immunotherapy requiring careful planning and execution. Under the expert care of Dr. Satyendra Katewa, every step is carefully planned to ensure safety, effectiveness, and optimal results.
Timeline of CAR T-Cell Therapy in Delhi ( From Start to Recovery)
Understanding the CAR T therapy timeline helps patients and families prepare for treatment and recovery.
- Week 1: Initial evaluation, tests, and eligibility confirmation
- Week 2: Leukapheresis (T-cell collection)
- Week 3-5: Laboratory modification and cell expansion
- Week 5: Lymphodepletion chemotherapy
- Week 5-6: CAR T-cell infusion
- Week 6-8: Hospital monitoring and early recovery
- 1-3 Months: Follow-up scans and response assessment
The entire CAR T-cell therapy process in Delhi usually takes 4-8 weeks, followed by long-term monitoring to ensure a well-sustained treatment.
CAR T-Cell Therapy Success Rate in India
The success rate of CAR T-cell therapy depends on the cancer type and the patient’s condition, but on average, the clinical outcomes are:
- Acute Lymphoblastic Leukemia (ALL): 70-90% remission rates
- Lymphomas: 50-70% response rates
- Multiple Myeloma: Significant response in advanced cases
These results make CAR T-cell therapy in Delhi a promising option for patients with limited options.
Side Effects and Risks of CAR T-Cell Therapy
While highly effective, the side effects of CAR T therapy require expert management. Common risks can be:
- Cytokine Release Syndrome (CRS): Fever, low BP, inflammation are seen in some cases
- Neurotoxicity syndrome: Can cause confusion, speech difficulty
- Infections due to low immunity
- Prolonged low blood counts
All complications are managed in specialised centres offering CAR T-cell therapy in Delhi with comprehensive care and support.
Cost of CAR T-Cell Therapy in Delhi
The CAR T therapy cost in Delhi depends on multiple factors like cancer type and stage, hospital infrastructure, and management of side effects.
Average cost range:
| Component | Cost (INR) |
| Imported CAR T therapy | ₹35-45 lakh+ |
| India-manufactured CAR T | ₹15-25 lakh |
| Pre-treatment & tests | ₹1-2.5 lakh |
| Hospitalisation | ₹1.5-3 lakh |
Under the expert guidance of Dr. Satyendra Katewa, transparent cost discussions take place during the initial consultation, allowing families to plan appropriately for this potentially life-saving treatment.
Recovery and Follow-Up Care After CAR T Therapy
CAR T therapy recovery time varies, but typically includes:
Recovery Period:
- Hospital stay: 1-2 weeks
- Monitoring phase: 1-3 months
- Long-term follow-up: Regular scans and blood tests
Nutrition After CAR T-Cell Therapy
A well-balanced diet plays an important role in recovery after CAR T-cell therapy, especially as the immune system may be temporarily weakened.
- High-protein foods
Supports tissue repair and immune recovery
(eggs, dairy, pulses, lean meats) - Fresh fruits and vegetables
Provide essential vitamins and antioxidants - Adequate hydration
Helps manage fatigue and supports overall recovery - Small, frequent meals
Useful for patients experiencing low appetite - Well-cooked and hygienic food
Reduces the risk of infection during the low-immunity phase
Patients require close supervision to ensure safe recovery and durable results.
Why Choose Dr. Satyendra Katewa for CAR T-Cell Therapy in Delhi
For patients searching for the best doctor for CAR T therapy in Delhi NCR, Dr. Satyendra Katewa offers:
- 25+ years of experience in advanced therapies, including CAR T and BMT
- Evidence-based, personalised treatment planning
- Management of complex cases and treatment complications
- Long-term follow-up and remission care
- Renowned globally for his work in pediatric bone marrow transplants
Why International Patients Choose CAR T-Cell Therapy in Delhi?
Dr. Satyendra Katewa welcomes international patients seeking options for CAR T-Cell Therapy in India, offering access to advanced cancer immunotherapy with experienced haematology-oncology expertise.
- Access to advanced CAR T-cell therapy for leukemia and lymphoma
- Availability of both imported and India-manufactured CAR T therapies
- Modern hospitals with an ICU and specialised oncology infrastructure
- Significantly lower cost compared to Western countries
International patients can share their medical reports, biopsy results, and treatment history in advance for an initial assessment. A personalised treatment plan, including eligibility for CAR T therapy, estimated cost, and expected timeline, will be provided before travel.
Start Your Treatment Journey with CAR T-Cell Therapy in Delhi
If you are considering CAR T-Cell Therapy in Delhi for leukemia, lymphoma, or other advanced blood cancers, taking the first step with a specialist evaluation can make a positive difference in your treatment results.
Early consultation helps determine:
- Your eligibility for CAR T-cell therapy
- The most appropriate treatment plan based on your condition
- Estimated cost, timeline, and expected outcomes
- Alternative or supportive treatment options, if needed
Under the guidance of Dr. Satyendra Katewa, each case is carefully reviewed to ensure a personalised, evidence-based approach planned according to your case requirements.
Whether you are seeking a second opinion or exploring advanced treatment options after previous therapies, expert guidance can help you make informed decisions with confidence.
Dr. Satyendra Katewa's Medical Content Team
Dr. Satyendra Katewa’s medical content team specialises in developing accurate, evidence-based, and patient-focused healthcare content. With strong clinical insight and expertise in medical writing and SEO, the team simplifies complex haematology and oncology information into clear, trustworthy resources that support informed decision-making and reflect Dr. Katewa’s commitment to ethical, compassionate care.
This content is reviewed by Dr. Satyendra Katewa
Related Blogs
Best Treatment Options for Leukaemia in Children
Leukaemia is the most common cancer affecting children. If your child has been diagnosed with…
Read Article →
Recovery After Bone Marrow Transplant in Children
A bone marrow transplant (BMT) is a life-saving treatment for many childhood cancers and blood…
Read Article →
Early Signs of Blood Cancer in Children: What Every Parent Should Know
Seeing your child unwell can make any parent anxious. Most childhood illnesses, such as fever,…
Read Article →